BDX - Becton, Dickinson and Company

The Dividend Aristocrats Ranked By Quality Scores (October 2026)

I rank all 69 S&P 500 Dividend Aristocrats by my 9F Quality Scores, segmenting them into undervalued, fairly valued, and overvalued groups. My consensus fair value estimates, blending up to 40 data points per stock, highlight 12 undervalued and 18 fairly valued Aristocrats, with 39 currently overvalued. Investment candidates vary by style: ADP, BRO, and NDSN for growth; NEE for total return; PEP and O for income; CAT and GWW for past performance.

Oct 23, 2026 08:25 AM • seekingalpha.com

BDX Stock Gains 25.5% in Six Months: What's Behind the Rally?

BD's 25.5% rally reflects stronger execution, portfolio reshaping, product innovation and U.S. manufacturing investments despite tariffs and cost pressures.

Oct 22, 2026 11:26 AM • zacks.com

3,815 Becton, Dickinson and Company $BDX Shares Bought by CFS Investment Advisory Services LLC

CFS Investment Advisory Services LLC raised its holdings in Becton, Dickinson and Company (NYSE: BDX) by 144.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,451 shares of the medical instruments supplier's stock after purchasing an additional 3,815 shares during

Oct 21, 2026 01:01 AM • defenseworld.net

Becton, Dickinson and Company $BDX Position Trimmed by Louisbourg Investments Inc.

Louisbourg Investments Inc. decreased its position in Becton, Dickinson and Company (NYSE: BDX) by 7.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 44,940 shares of the medical instruments supplier's stock after selling 3,375 shares during the quarter.

Oct 21, 2026 12:09 AM • defenseworld.net

Becton, Dickinson and Company $BDX Stock Sold by Forbes J M & Co. LLP

Forbes J M and Co. LLP cut its holdings in shares of Becton, Dickinson and Company (NYSE: BDX) by 86.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,901 shares of the medical instruments supplier's stock after selling

Oct 18, 2026 01:47 AM • defenseworld.net

Becton, Dickinson and Company $BDX Position Boosted by Birch Hill Investment Advisors LLC

Birch Hill Investment Advisors LLC raised its position in Becton, Dickinson and Company (NYSE: BDX) by 862.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 21,321 shares of the medical instruments supplier's stock after purchasing an additional 19,106 shares

Oct 18, 2026 01:06 AM • defenseworld.net

BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients

BDX's Revello stent shows strong nine-month AGILITY trial results, with high vessel patency and low failure rates, boosting its peripheral vascular prospects.

Oct 15, 2026 10:25 AM • zacks.com

3 Overlooked Healthcare Dividend Stocks That Could Keep Paying for Decades

Most income investors chase flashy yields and overlook the quiet compounders that have raised their dividends through recessions, rate shocks, and global pandemics.

Oct 15, 2026 07:45 AM • 247wallst.com

Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?

Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Oct 09, 2026 09:10 AM • zacks.com

Becton, Dickinson and Company $BDX Shares Acquired by YHB Investment Advisors Inc.

YHB Investment Advisors Inc. boosted its holdings in Becton, Dickinson and Company (NYSE: BDX) by 134.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,874 shares of the medical instruments supplier's stock after purchasing an additional

Oct 09, 2026 12:25 AM • defenseworld.net

BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2026

FRANKLIN LAKES, N.J., Oct. 8, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m.

Oct 08, 2026 12:15 PM • prnewswire.com

BD and Global Health Leaders Call for Accelerated Maternal Life Saving Measures Worldwide

Physicians, policymakers, and global health experts urge broader access to monitoring technologies that can help identify life-threatening complications earlier, helping more mothers survive childbirth and giving babies a healthier start in life. FRANKLIN LAKES, N.J.

Oct 08, 2026 02:50 AM • prnewswire.com

BDX Expands U.S. Manufacturing With $19B Healthcare Investment

BD plans a $19B U.S. investment, including $3B for manufacturing, to boost domestic medical consumables capacity and supply-chain resilience.

Oct 07, 2026 08:56 AM • zacks.com

BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results

Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing evidence supporting the treatment of complex iliac artery disease. FRANKLIN LAKES, N.J.

Oct 07, 2026 04:00 AM • prnewswire.com

Becton Dickinson Commits Massive $19 Billion To Expand Domestic Medical Manufacturing

Becton, Dickinson and Company (NYSE:BDX), a global medical technology firm and the largest domestic producer of critical medical consumables, on Tuesday announced a monumental partnership with the U.S. government.

Oct 06, 2026 08:30 AM • benzinga.com

BD Celebrates 65 Years of Manufacturing, Innovation and Community Partnership in Canaan

Generations of Connecticut employees have helped ensure the reliable supply of the BD® Syringe, an essential medical device clinicians rely on every day in patient care around the world CANAAN, Conn., Oct. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today marked 65 years of manufacturing in Canaan, Conn.

Oct 06, 2026 05:00 AM • prnewswire.com

BD Appoints Ferass Abuzaina as Worldwide President of Surgery

FRANKLIN LAKES, N.J., Oct. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Ferass Abuzaina has been named worldwide president of the Surgery business unit at BD, effective immediately.

Oct 06, 2026 02:50 AM • prnewswire.com

BD and U.S. Government Launch Landmark Partnership to Expand U.S. Manufacturing and Strengthen America's Healthcare Resilience

Agreement supports significant investments in U.S. manufacturing, strengthens healthcare resilience and increases domestic production of essential medical consumables used in approximately 90% of U.S. hospital visits    FRANKLIN LAKES, N.J., Oct. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), one of the world's leading medical technology companies and the nation's largest manufacturer of essential medical consumables, today announced a landmark partnership with the U.S. Government to expand domestic manufacturing and strengthen the resilience of supply chains for essential medical consumables relied on by clinicians and patients every day.

Oct 06, 2026 02:35 AM • prnewswire.com

Trump says Becton Dickinson to invest $3 billion to expand US medical product manufacturing

American ​medical technology company Becton ‌Dickinson has agreed to invest $3 billion ​to bring manufacturing ​of essential medical products ⁠to the United ​States, President Donald ​Trump said on Monday in a post on the ​Truth Social ​website.

Oct 05, 2026 07:41 PM • reuters.com

Becton, Dickinson and Company $BDX Shares Sold by Park National Corp OH

Park National Corp OH cut its holdings in Becton, Dickinson and Company (NYSE: BDX) by 18.3% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 48,535 shares of the medical instruments supplier's stock after selling 10,859 shares during the period. Park National Corp OH's holdings

Oct 05, 2026 09:37 AM • defenseworld.net

Becton Dickinson initiated with an Underweight at Barclays (yesterday)

$165.00 (was $179.62)

Christopher Pasquale · Barclays

Oct 07, 2026 09:50 AM • TheFly

Becton Dickinson price target raised to $190 from $180 at RBC Capital

$190.00 (was $184.04)

RBC Capital

Aug 13, 2026 09:14 AM • TheFly

Becton Dickinson price target raised to $195 from $175 at Stifel

$195.00 (was $176.07)

Stifel Nicolaus

Aug 07, 2026 09:06 AM • TheFly

Becton Dickinson price target raised to $180 from $175 at RBC Capital

$180.00 (was $176.25)

Shagun Singh · RBC Capital

Aug 07, 2026 08:06 AM • TheFly

Becton Dickinson price target raised to $210 from $190 at Jefferies

$210.00 (was $176.91)

Jefferies

Aug 06, 2026 01:57 PM • TheFly

Becton Dickinson initiated with a Buy at UBS

$190.00 (was $158.92)

UBS

Jul 28, 2026 06:33 AM • TheFly

Becton Dickinson price target lowered to $180 from $190 at Evercore ISI

$180.00 (was $154.59)

Evercore ISI

Jul 06, 2026 08:40 AM • TheFly

Becton Dickinson price target raised to $204 from $202 at Barclays

$204.00 (was $149.43)

Barclays

May 11, 2026 05:26 AM • TheFly

Becton Dickinson price target lowered to $159 from $170 at Piper Sandler

$159.00 (was $154.82)

Jason Bednar · Piper Sandler

Apr 17, 2026 07:40 AM • TheFly

Becton Dickinson price target lowered to $175 from $195 at RBC Capital

$175.00 (was $155.43)

RBC Capital

Apr 14, 2026 07:17 AM • TheFly

Becton Dickinson resumed with a Neutral at Goldman Sachs

$167.00 (was $154.42)

David Roman · Goldman Sachs

Apr 10, 2026 12:09 AM • TheFly

Becton Dickinson price target lowered to $172 from $210 at RBC Capital

$172.00 (was $170.14)

Shagun Singh · RBC Capital

Feb 10, 2026 08:54 AM • TheFly

Becton Dickinson reinstated with an Overweight at Barclays

$202.00 (was $207.39)

Matt Miksic · Barclays

Feb 10, 2026 07:15 AM • TheFly

Becton Dickinson price target lowered to $170 from $205 at Piper Sandler

$170.00 (was $207.39)

Piper Sandler

Feb 10, 2026 06:28 AM • TheFly

Becton Dickinson price target raised to $205 from $190 at Piper Sandler

$205.00 (was $159.91)

Jason Bednar · Piper Sandler

Jan 28, 2026 06:51 AM • TheFly

Becton Dickinson price target raised to $215 from $210 at Stifel

$215.00 (was $161.45)

Stifel Nicolaus

Jan 07, 2026 07:34 AM • TheFly

Becton Dickinson price target raised to $210 from $202 at RBC Capital

$210.00 (was $154.39)

RBC Capital

Dec 17, 2025 07:23 AM • TheFly

Becton Dickinson price target raised to $210 from $197 at Morgan Stanley

$210.00 (was $150.80)

Patrick Wood · Morgan Stanley

Dec 02, 2025 06:37 AM • TheFly

Becton Dickinson price target lowered to $260 from $280 at Piper Sandler

$260.00 (was $159.06)

Jason Bednar · Piper Sandler

Apr 23, 2025 07:35 AM • TheFly

Becton Dickinson target raised, added to 'Tactical Outperform' list at Evercore

$290.00 (was $189.54)

Vijay Kumar · Evercore ISI

Oct 01, 2024 04:38 AM • TheFly